Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 169 entries
Sorted by: Best Match Show Resources per page
Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.

JAMA network open

Coffey B, Jankovic J, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander JK, Barkay H, Harary E.
PMID: 34661664
JAMA Netw Open. 2021 Oct 01;4(10):e2129397. doi: 10.1001/jamanetworkopen.2021.29397.

IMPORTANCE: Tourette syndrome is a neurodevelopmental disorder characterized by childhood onset of motor and phonic tics, often accompanied by behavioral and psychiatric comorbidities. Deutetrabenazine is a vesicular monoamine transporter 2 inhibitor approved in the US for the treatment of...

Cite
Coffey B, Jankovic J, Claassen DO, et al. Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(10):e2129397doi: 10.1001/jamanetworkopen.2021.29397.
Coffey, B., Jankovic, J., Claassen, D. O., Jimenez-Shahed, J., Gertz, B. J., Garofalo, E. A., Stamler, D. A., Wieman, M., Savola, J. M., Gordon, M. F., Alexander, J. K., Barkay, H., & Harary, E. (2021). Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial. JAMA network open, 4(10), e2129397. https://doi.org/10.1001/jamanetworkopen.2021.29397
Coffey, Barbara, et al. "Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial." JAMA network open vol. 4,10 (2021): e2129397. doi: https://doi.org/10.1001/jamanetworkopen.2021.29397
Coffey B, Jankovic J, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander JK, Barkay H, Harary E. Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2021 Oct 01;4(10):e2129397. doi: 10.1001/jamanetworkopen.2021.29397. PMID: 34661664; PMCID: PMC8524312.
Copy Download .nbib Format: NLM
Comparison of three .

Virulence

Miller HK, Priestley RA, Kersh GJ.
PMID: 34569895
Virulence. 2021 Dec;12(1):2562-2570. doi: 10.1080/21505594.2021.1980179.

Evidence suggests that

Cite
Miller HK, Priestley RA, Kersh GJ. Comparison of three . Virulence. 2021;12(1):2562-2570doi: 10.1080/21505594.2021.1980179.
Miller, H. K., Priestley, R. A., & Kersh, G. J. (2021). Comparison of three . Virulence, 12(1), 2562-2570. https://doi.org/10.1080/21505594.2021.1980179
Miller, Halie K, et al. "Comparison of three ." Virulence vol. 12,1 (2021): 2562-2570. doi: https://doi.org/10.1080/21505594.2021.1980179
Miller HK, Priestley RA, Kersh GJ. Comparison of three . Virulence. 2021 Dec;12(1):2562-2570. doi: 10.1080/21505594.2021.1980179. PMID: 34569895; PMCID: PMC8477946.
Copy Download .nbib Format: NLM
Flow control in a laminate capillary-driven microfluidic device.

The Analyst

Jang I, Kang H, Song S, Dandy DS, Geiss BJ, Henry CS.
PMID: 33492316
Analyst. 2021 Mar 21;146(6):1932-1939. doi: 10.1039/d0an02279a. Epub 2021 Jan 25.

Capillary-driven microfluidic devices are of significant interest for on-site analysis because they do not require external pumps and can be made from inexpensive materials. Among capillary-driven devices, those made from paper and polyester film are among the most common...

Cite
Jang I, Kang H, Song S, et al. Flow control in a laminate capillary-driven microfluidic device. Analyst. 2021;146(6):1932-1939doi: 10.1039/d0an02279a.
Jang, I., Kang, H., Song, S., Dandy, D. S., Geiss, B. J., & Henry, C. S. (2021). Flow control in a laminate capillary-driven microfluidic device. The Analyst, 146(6), 1932-1939. https://doi.org/10.1039/d0an02279a
Jang, Ilhoon, et al. "Flow control in a laminate capillary-driven microfluidic device." The Analyst vol. 146,6 (2021): 1932-1939. doi: https://doi.org/10.1039/d0an02279a
Jang I, Kang H, Song S, Dandy DS, Geiss BJ, Henry CS. Flow control in a laminate capillary-driven microfluidic device. Analyst. 2021 Mar 21;146(6):1932-1939. doi: 10.1039/d0an02279a. Epub 2021 Jan 25. PMID: 33492316; PMCID: PMC7990706.
Copy Download .nbib Format: NLM
[No title available]

Virulence

Priestley RA, Smith CB, Miller HK, Kersh GJ.
PMID: 34516359
Virulence. 2021 Dec;12(1):2461-2473. doi: 10.1080/21505594.2021.1975527.

No abstract available.

Cite
Priestley RA, Smith CB, Miller HK, et al. . Virulence. 2021;12(1):2461-2473doi: 10.1080/21505594.2021.1975527.
Priestley, R. A., Smith, C. B., Miller, H. K., & Kersh, G. J. (2021). . Virulence, 12(1), 2461-2473. https://doi.org/10.1080/21505594.2021.1975527
Priestley, Rachael A, et al. "." Virulence vol. 12,1 (2021): 2461-2473. doi: https://doi.org/10.1080/21505594.2021.1975527
Priestley RA, Smith CB, Miller HK, Kersh GJ. . Virulence. 2021 Dec;12(1):2461-2473. doi: 10.1080/21505594.2021.1975527. PMID: 34516359; PMCID: PMC8451504.
Copy Download .nbib Format: NLM
HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy.

Hepatology (Baltimore, Md.)

Mak LY, Cloherty G, Wong DK, Gersch J, Seto WK, Fung J, Yuen MF.
PMID: 33159329
Hepatology. 2021 Jun;73(6):2167-2179. doi: 10.1002/hep.31616.

BACKGROUND AND AIMS: Large-scale comprehensive studies on HBV RNA in chronic hepatitis B are lacking. We aimed to study the HBV RNA profile and its correlation with other viral markers in patients with chronic hepatitis B who are treatment-naïve...

Cite
Mak LY, Cloherty G, Wong DK, et al. HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy. Hepatology. 2021;73(6):2167-2179doi: 10.1002/hep.31616.
Mak, L. Y., Cloherty, G., Wong, D. K., Gersch, J., Seto, W. K., Fung, J., & Yuen, M. F. (2021). HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy. Hepatology (Baltimore, Md.), 73(6), 2167-2179. https://doi.org/10.1002/hep.31616
Mak, Lung-Yi, et al. "HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy." Hepatology (Baltimore, Md.) vol. 73,6 (2021): 2167-2179. doi: https://doi.org/10.1002/hep.31616
Mak LY, Cloherty G, Wong DK, Gersch J, Seto WK, Fung J, Yuen MF. HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy. Hepatology. 2021 Jun;73(6):2167-2179. doi: 10.1002/hep.31616. PMID: 33159329.
Copy Download .nbib Format: NLM
Epidemiological Trends in the Timing of In-Hospital Death in Acute Myocardial Infarction-Cardiogenic Shock in the United States.

Journal of clinical medicine

Vallabhajosyula S, Dunlay SM, Bell MR, Miller PE, Cheungpasitporn W, Sundaragiri PR, Kashani K, Gersh BJ, Jaffe AS, Holmes DR, Barsness GW.
PMID: 32635255
J Clin Med. 2020 Jul 03;9(7). doi: 10.3390/jcm9072094.

BACKGROUND: There are limited data on the epidemiology and timing of in-hospital death (IHD) in patients with acute myocardial infarction-cardiogenic shock (AMI-CS).METHODS: Adult admissions with AMI-CS with IHDs were identified using the National Inpatient Sample (2000-2016) and were classified...

Cite
Vallabhajosyula S, Dunlay SM, Bell MR, et al. Epidemiological Trends in the Timing of In-Hospital Death in Acute Myocardial Infarction-Cardiogenic Shock in the United States. J Clin Med. 2020;9(7)doi: 10.3390/jcm9072094.
Vallabhajosyula, S., Dunlay, S. M., Bell, M. R., Miller, P. E., Cheungpasitporn, W., Sundaragiri, P. R., Kashani, K., Gersh, B. J., Jaffe, A. S., Holmes, D. R., & Barsness, G. W. (2020). Epidemiological Trends in the Timing of In-Hospital Death in Acute Myocardial Infarction-Cardiogenic Shock in the United States. Journal of clinical medicine, 9(7), . https://doi.org/10.3390/jcm9072094
Vallabhajosyula, Saraschandra, et al. "Epidemiological Trends in the Timing of In-Hospital Death in Acute Myocardial Infarction-Cardiogenic Shock in the United States." Journal of clinical medicine vol. 9,7 (2020). doi: https://doi.org/10.3390/jcm9072094
Vallabhajosyula S, Dunlay SM, Bell MR, Miller PE, Cheungpasitporn W, Sundaragiri PR, Kashani K, Gersh BJ, Jaffe AS, Holmes DR, Barsness GW. Epidemiological Trends in the Timing of In-Hospital Death in Acute Myocardial Infarction-Cardiogenic Shock in the United States. J Clin Med. 2020 Jul 03;9(7). doi: 10.3390/jcm9072094. PMID: 32635255; PMCID: PMC7408956.
Copy Download .nbib Format: NLM
HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy.

Hepatology (Baltimore, Md.)

Mak LY, Cloherty G, Wong DK, Gersch J, Seto WK, Fung J, Yuen MF.
PMID: 33159329
Hepatology. 2021 Jun;73(6):2167-2179. doi: 10.1002/hep.31616.

BACKGROUND AND AIMS: Large-scale comprehensive studies on HBV RNA in chronic hepatitis B are lacking. We aimed to study the HBV RNA profile and its correlation with other viral markers in patients with chronic hepatitis B who are treatment-naïve...

Cite
Mak LY, Cloherty G, Wong DK, et al. HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy. Hepatology. 2021;73(6):2167-2179doi: 10.1002/hep.31616.
Mak, L. Y., Cloherty, G., Wong, D. K., Gersch, J., Seto, W. K., Fung, J., & Yuen, M. F. (2021). HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy. Hepatology (Baltimore, Md.), 73(6), 2167-2179. https://doi.org/10.1002/hep.31616
Mak, Lung-Yi, et al. "HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy." Hepatology (Baltimore, Md.) vol. 73,6 (2021): 2167-2179. doi: https://doi.org/10.1002/hep.31616
Mak LY, Cloherty G, Wong DK, Gersch J, Seto WK, Fung J, Yuen MF. HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy. Hepatology. 2021 Jun;73(6):2167-2179. doi: 10.1002/hep.31616. PMID: 33159329.
Copy Download .nbib Format: NLM
Spotlight on N-STEMI ACS: getting the right patients the right treatment, and at the right time.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Kite TA, Gersh BJ, Gershlick AH.
PMID: 31857276
EuroIntervention. 2019 Dec 20;15(12):e1041-e1045. doi: 10.4244/EIJV15I12A196.

No abstract available.

Cite
Kite TA, Gersh BJ, Gershlick AH. Spotlight on N-STEMI ACS: getting the right patients the right treatment, and at the right time. EuroIntervention. 2019;15(12):e1041-e1045doi: 10.4244/EIJV15I12A196.
Kite, T. A., Gersh, B. J., & Gershlick, A. H. (2019). Spotlight on N-STEMI ACS: getting the right patients the right treatment, and at the right time. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 15(12), e1041-e1045. https://doi.org/10.4244/EIJV15I12A196
Kite, Thomas A, et al. "Spotlight on N-STEMI ACS: getting the right patients the right treatment, and at the right time." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 15,12 (2019): e1041-e1045. doi: https://doi.org/10.4244/EIJV15I12A196
Kite TA, Gersh BJ, Gershlick AH. Spotlight on N-STEMI ACS: getting the right patients the right treatment, and at the right time. EuroIntervention. 2019 Dec 20;15(12):e1041-e1045. doi: 10.4244/EIJV15I12A196. PMID: 31857276.
Copy Download .nbib Format: NLM
The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy.

Mayo Clinic proceedings

Gersh FL, O'Keefe JH, Lavie CJ, Henry BM.
PMID: 34736778
Mayo Clin Proc. 2021 Dec;96(12):3130-3141. doi: 10.1016/j.mayocp.2021.08.009. Epub 2021 Nov 02.

Estradiol (E2) plays an underrecognized role in modulating body-wide systems, including important interactions with the renin-angiotensin-aldosterone system (RAAS). The RAAS is an immunomodulating system that is critical for maintaining homeostasis across multiple organ systems. The diverse interactions between E2...

Cite
Gersh FL, O'Keefe JH, Lavie CJ, et al. The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy. Mayo Clin Proc. 2021;96(12):3130-3141doi: 10.1016/j.mayocp.2021.08.009.
Gersh, F. L., O'Keefe, J. H., Lavie, C. J., & Henry, B. M. (2021). The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy. Mayo Clinic proceedings, 96(12), 3130-3141. https://doi.org/10.1016/j.mayocp.2021.08.009
Gersh, Felice L, et al. "The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy." Mayo Clinic proceedings vol. 96,12 (2021): 3130-3141. doi: https://doi.org/10.1016/j.mayocp.2021.08.009
Gersh FL, O'Keefe JH, Lavie CJ, Henry BM. The Renin-Angiotensin-Aldosterone System in Postmenopausal Women: The Promise of Hormone Therapy. Mayo Clin Proc. 2021 Dec;96(12):3130-3141. doi: 10.1016/j.mayocp.2021.08.009. Epub 2021 Nov 02. PMID: 34736778.
Copy Download .nbib Format: NLM
Developmental origins and transgenerational inheritance of polycystic ovary syndrome.

The Australian & New Zealand journal of obstetrics & gynaecology

Parker J, O'Brien C, Gersh FL.
PMID: 34403138
Aust N Z J Obstet Gynaecol. 2021 Dec;61(6):922-926. doi: 10.1111/ajo.13420. Epub 2021 Aug 17.

BACKGROUND: There has been increasing awareness that polycystic ovary syndrome (PCOS) phenotypes may represent a mismatch between ancient genetically programmed metabolic and reproductive survival mechanisms and modern lifestyle practices. In-utero developmental programming of metabolic and endocrine pathways may play...

Cite
Parker J, O'Brien C, Gersh FL. Developmental origins and transgenerational inheritance of polycystic ovary syndrome. Aust N Z J Obstet Gynaecol. 2021;61(6):922-926doi: 10.1111/ajo.13420.
Parker, J., O'Brien, C., & Gersh, F. L. (2021). Developmental origins and transgenerational inheritance of polycystic ovary syndrome. The Australian & New Zealand journal of obstetrics & gynaecology, 61(6), 922-926. https://doi.org/10.1111/ajo.13420
Parker, Jim, et al. "Developmental origins and transgenerational inheritance of polycystic ovary syndrome." The Australian & New Zealand journal of obstetrics & gynaecology vol. 61,6 (2021): 922-926. doi: https://doi.org/10.1111/ajo.13420
Parker J, O'Brien C, Gersh FL. Developmental origins and transgenerational inheritance of polycystic ovary syndrome. Aust N Z J Obstet Gynaecol. 2021 Dec;61(6):922-926. doi: 10.1111/ajo.13420. Epub 2021 Aug 17. PMID: 34403138.
Copy Download .nbib Format: NLM
Myocardial perfusion and ACE inhibition.

Reviews in cardiovascular medicine

Gersh BJ.
PMID: 12506938
Rev Cardiovasc Med. 2000;1(2):75-8.

No abstract available.

Cite
Gersh BJ. Myocardial perfusion and ACE inhibition. Rev Cardiovasc Med. 2000;1(2):75-8
Gersh, B. J. (2000). Myocardial perfusion and ACE inhibition. Reviews in cardiovascular medicine, 1(2), 75-8.
Gersh, B J. "Myocardial perfusion and ACE inhibition." Reviews in cardiovascular medicine vol. 1,2 (2000): 75-8.
Gersh BJ. Myocardial perfusion and ACE inhibition. Rev Cardiovasc Med. 2000;1(2):75-8. PMID: 12506938.
Copy Download .nbib Format: NLM
Extinction of a human cardiac-response during avoidance-conditioning.

The American journal of psychology

BERSH PJ, NOTTERMAN JM, SCHOENFELD WN.
PMID: 13327085
Am J Psychol. 1956 Jun;69(2):244-51.

No abstract available.

Cite
BERSH PJ, NOTTERMAN JM, SCHOENFELD WN. Extinction of a human cardiac-response during avoidance-conditioning. Am J Psychol. 1956;69(2):244-51
BERSH, P. J., NOTTERMAN, J. M., & SCHOENFELD, W. N. (1956). Extinction of a human cardiac-response during avoidance-conditioning. The American journal of psychology, 69(2), 244-51.
BERSH, P J, et al. "Extinction of a human cardiac-response during avoidance-conditioning." The American journal of psychology vol. 69,2 (1956): 244-51.
BERSH PJ, NOTTERMAN JM, SCHOENFELD WN. Extinction of a human cardiac-response during avoidance-conditioning. Am J Psychol. 1956 Jun;69(2):244-51. PMID: 13327085.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 169 entries